ANGO - AngioDynamics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue 5/31/2019 5/31/2018 5/31/2017 5/31/2016
Total Revenue 270,634 261,655 269,788 351,474
Cost of Revenue 114,634 117,799 124,001 179,574
Gross Profit 156,000 143,856 145,787 171,900
Operating Expenses
Research Development 28,258 24,338 24,148 25,053
Selling General and Administrative 111,731 104,100 105,998 114,326
Non Recurring - - - -
Others - - - -
Total Operating Expenses 271,679 260,143 268,714 336,917
Operating Income or Loss -1,045 1,512 1,074 14,557
Income from Continuing Operations
Total Other Income/Expenses Net -13,657 -18,775 -15,369 -17,810
Earnings Before Interest and Taxes -1,045 1,512 1,074 14,557
Interest Expense -5,099 -3,062 -2,839 -3,385
Income Before Tax -14,702 -17,263 -14,295 -3,253
Income Tax Expense -3,556 -11,036 -7,243 40,337
Minority Interest - - - -
Net Income From Continuing Ops -11,146 -6,227 -7,052 -43,590
Non-recurring Events
Discontinued Operations 72,486 22,562 12,060 12,060
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income
Net Income 61,340 16,335 5,008 -43,590
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares 61,340 16,335 5,008 -43,590